A phase 3 randomized trial of the safety and immunogenicity of 20-valent pneumococcal conjugate vaccine in adults ≥ 60 years of age in Japan, South Korea, and Taiwan
Author:
Funder
Pfizer
Publisher
Elsevier BV
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference38 articles.
1. Pneumococcal infection in adults: burden of disease;Drijkoningen;Clin Microbiol Infect,2014
2. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the global burden of disease study 2019;GBD Antimicrobial Resistance Collaborators;Lancet,2022
3. The burden and etiology of community-onset pneumonia in the aging Japanese population: A multicenter prospective study;Morimoto;PLoS One,2015
4. Disease burden of hospitalized community-acquired pneumonia in South Korea: Analysis based on age and underlying medical conditions;Choi;Medicine (Baltimore),2017
5. A retrospective study to assess the epidemiological and economic burden of pneumococcal diseases in adults aged 50 years and older in Taiwan;Wu;J Med Econ,2014
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3